Ken James
Fortuna: 7 004 $ al 31/05/2026
Fortuna: 7 004 $ al 31/05/2026
Ken James is currently Executive Director, Head-Research & Development at Futura Medical Plc since 2016.
Formerly, Mr. James was Director at Futura Medical Developments Ltd. Mr. James was Senior Vice President-Research & Development at Glaxo SmithKline Consumer Healthcare Ltd. from 2006 to 2016.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
FUTURA MEDICAL PLC 0,14 % | 31/12/2025 | 799.501 ( 0,14 % ) | 7 004 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| FUTURA MEDICAL PLC | Director Técnico/Científico/I+D | 16/11/2016 |
| Empresas | Cargo | Fin |
|---|---|---|
Glaxo SmithKline Consumer Healthcare Ltd.
Glaxo SmithKline Consumer Healthcare Ltd. Medical DistributorsDistribution Services Manufactures and supplies over the counter drugs | Director Técnico/Científico/I+D | 01/02/2016 |
Futura Medical Developments Ltd.
Futura Medical Developments Ltd. BiotechnologyHealth Technology Develops biological products | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Futura Medical Plc
Futura Medical Plc Pharmaceuticals: OtherHealth Technology Produces pharmaceutical products | Health Technology |
Glaxo SmithKline Consumer Healthcare Ltd.
Glaxo SmithKline Consumer Healthcare Ltd. Medical DistributorsDistribution Services Manufactures and supplies over the counter drugs | Distribution Services |
Futura Medical Developments Ltd.
Futura Medical Developments Ltd. BiotechnologyHealth Technology Develops biological products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.